Therefore, the use of PLTs to entrap MCUR1 inhibitors in HCC therapy is of great interest, as it may effectively reduce MDR in tumor tissue, resulting in a better therapeutic outcome. This evidence concerns the gene MCUR1 and hepatocellular carcinoma.